Ranking of genotypes according to the ideotype for each trait and the percentage difference (increase or decrease) in relation to cv. M-82. by Herika Paula Pessoa (13254326)

Means, standard deviations and intercorrelations. by Cheri Ostroff (13868468)

The average means of hemoglobin level across the hospitals (N = 42). by Wilhellmuss I. Mauka (5233805)

Fermentation must reducing sugar (A, strain A; B, strain B; C, strain F) and fermentation ethanol concentration (D, strain A; E, strain B; F, strain F) for <i>S. cerevisiae</i> str... by Xiang-yu Sun (748032)

Populations activity of the <i>eirs</i>-NFT model. by Felipe A. Torres (11210983)

Fig 2 - by Masaru Sakai (1669627)

Survey weighted means (± S.E.) for study cohorts. by Joseph M. Collaco (195530)

Parameters for the seven ODE models. by Hope Murphy (8843516)

K562 cells were treated with 40 nM of miR-214 mimics or a negative mimics control for 24 h, followed by treatment with 50 μM of hemin for 48 h. by Tipparat Penglong (164413)

Aged blood factors decrease cellular responses associated with delayed gingival wound repair by María Paz Saldías (4430032)

“…<div><p>Aging is a gradual biological process characterized by a decrease in cell and organism functions. …”

IC₅₀ (left) and <i>ε</i>_max (right) measurement time dependence for all seven models. by Hope Murphy (8843516)

Example of the process used to determine time dependence of <i>ε</i>_max and IC₅₀. by Hope Murphy (8843516)

Respiratory symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Other symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Gastrointestinal symptoms-free days up to day 10. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”

Pretreatment with Y-26732 Decreased Caspase-3 Activity in CSCs Induced by Dox. by Lijuan Kan (834976)

Removal ratio η (A) and adsorption efficiency <i>A</i> (B) of Cu²⁺ on <i>S</i>. <i>cerevisiae</i> strains AWRI R2 (A), BH8 (B) and Freddo (F) at the end of alcoholic fer... by Xiang-yu Sun (748032)

Area estimates in CAKR by percentage of the mean LSR of the 3000–4000 m distance class (41.9) according to the posterior predictions model. by Peter N. Neitlich (4034300)

<i>I</i>_<i>h</i> activation may increase or decrease the threshold for L5PC action potential firing by a strong apical dendritic input, depending on the location of the... by Tuomo Mäki-Marttunen (388882)

Mean SARS-CoV-2 viral load log 10 between groups. by Bruno Martins Tomazini (6509528)

“…</p><p>Results</p><p>From September 25, 2021, to February 3, 2022, 153 patients were randomized. The mean decay rate in SARS-CoV-2 viral load log₁₀ within 10 days was -3.75 (95% CI, -4.11; -3.19) in the placebo group, -3.83 (95% CI, -4.40; -2.27) in the halofuginone 0.5mg group and -4.13 (95% CI, -4.69; -3.57) in the halofuginone 1mg group, with no statistically significant difference in between placebo vs. halofuginone 0.5mg (mean difference -0.08; 95% CI -0.82 to 0.66, p = 0.96) and between placebo vs. halofuginone 1mg (mean difference -0.38; 95% CI, -1.11; 0.36, p = 0.41). …”